# COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF

> **NCT05054582** · — · COMPLETED · sponsor: **Medical University Innsbruck** · enrollment: 152 (actual)

## Conditions studied

- Cystic Fibrosis
- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05054582
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05054582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05054582, "COVID-19 Antibody Responses In Cystic Fibrosis: CAR-CF". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05054582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*